Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Depression in Kraepelinian schizophrenia.

Nael Kilzieh1, Amanda Ernst Wood, Jaime Erdmann

  • 1Veterans Affairs Puget Sound Health Care System, University of Washington, Seattle, WA, USA.

Comprehensive Psychiatry
|January 14, 2003
PubMed
Summary

Depression is less common in Kraepelinian schizophrenia patients, even those severely ill. This suggests Kraepelinian schizophrenia may be a distinct subtype, impacting depression

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multi-ancestry genome-wide meta-analysis of 56,241 individuals identifies known and novel cross-population and ancestry-specific associations as novel risk loci for Alzheimer's disease.

Genome biology·2025
Same author

Perivascular Space Burden and Cerebrospinal Fluid Biomarkers in US Veterans With Blast-Related Mild Traumatic Brain Injury.

Journal of neurotrauma·2024
Same author

A case of prazosin in treatment of rapid eye movement sleep behavior disorder.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine·2023
Same author

Multi-ancestry genome-wide meta-analysis of 56,241 individuals identifies <i>LRRC4C, LHX5-AS1</i> and nominates ancestry-specific loci <i>PTPRK</i> , <i>GRB14</i> , and <i>KIAA0825</i> as novel risk loci for Alzheimer's disease: the Alzheimer's Disease Genetics Consortium.

medRxiv : the preprint server for health sciences·2023
Same author

Medication Optimization Using Pharmacogenomic Testing in a Complex Mental Health Population Prescribed Psychiatric Polypharmacy.

Journal of clinical pharmacology·2022
Same author

Cognitive impairment and World Trade Centre-related exposures.

Nature reviews. Neurology·2021

Area of Science:

  • Psychiatry
  • Clinical Psychology
  • Neuroscience

Background:

  • Chronic schizophrenia, particularly the Kraepelinian subtype, presents unique challenges in understanding comorbid conditions.
  • Depression is a significant concern in schizophrenia, yet its prevalence varies across subtypes.
  • Previous research indicates differing depression rates in Kraepelinian versus non-Kraepelinian schizophrenia patients.

Purpose of the Study:

  • To investigate the prevalence and characteristics of depressive symptoms in institutionalized patients with chronic Kraepelinian schizophrenia.
  • To explore the relationship between depression and other symptom dimensions in this specific patient group.
  • To differentiate Kraepelinian schizophrenia from other subtypes and schizoaffective disorder.

Main Methods:

Related Experiment Videos

  • Assessment of depressive symptoms using the Hamilton Depression (HAM-D) scale in 43 institutionalized patients with chronic Kraepelinian schizophrenia.
  • Evaluation of general psychopathology, positive and negative symptoms using the Brief Psychiatric Rating Scale (BPRS) and Scale for the Assessment of Negative Symptoms (SANS).
  • Correlation analysis between depression scores and measures of general psychopathology, positive symptoms, negative symptoms, and extrapyramidal symptoms (EPS) using the Simpson-Angus Rating Scale (SAS).

    • Main Results:

    • Low prevalence of depressive symptoms, with only 5% of patients scoring above 16 on the HAM-D scale.
    • Minimal presence of core depressive symptoms such as depressed mood, suicidal ideation, and guilt.
    • Modest positive correlations found between depression and general psychopathology (r = 0.44) and extrapyramidal symptoms (r = 0.48), but not with positive or negative symptoms.
    • Depression was not prevalent even in severely ill patients with chronic Kraepelinian schizophrenia.

    Conclusions:

    • Kraepelinian schizophrenia appears to be a distinct subtype with a low prevalence of depression.
    • Findings challenge the diagnostic boundary between schizoaffective disorder and non-Kraepelinian schizophrenia.
    • The low rate of depression suggests that preserved core functional abilities may be necessary for depressive reactions to manifest in schizophrenia.